Melanie Kardel
About Melanie Kardel
Melanie Kardel is a Senior Scientist specializing in PSC Biology at Notch Therapeutics, with a strong background in stem cells and regenerative medicine. She has extensive experience in cell-based assay development and has contributed to significant advancements in therapeutic approaches for various diseases.
Current Role at Notch Therapeutics
Melanie Kardel serves as a Senior Scientist in PSC Biology at Notch Therapeutics. She has been in this role since 2020, focusing on the development of innovative treatments using pluripotent stem cells. Her work involves advancing research in regenerative medicine and contributing to the development of cell-based therapies.
Previous Experience in Stem Cell Research
Prior to her current position, Kardel worked at STEMCELL Technologies as a Senior Scientist from 2012 to 2020. Her experience also includes a postdoctoral position at the BC Cancer Agency from 2011 to 2012 and a role as a Research Technician at the University of Alberta from 2001 to 2003. This extensive background has equipped her with a strong foundation in stem cell biology and therapeutic applications.
Education and Expertise in Genetics
Melanie Kardel earned her Bachelor of Science (BSc) in Molecular Genetics from the University of Alberta from 1997 to 2001. She furthered her education at The University of British Columbia, obtaining a Doctor of Philosophy (PhD) in Genetics from 2003 to 2011. Her academic background supports her expertise in cell-based assay development and regenerative medicine.
Research Contributions and Conferences
Kardel has actively participated in various conferences to present her research. In January 2023, she presented at the Keystone—Emerging Cellular Therapies conference. She also contributed to research presented at the ISSCR 2023 conference and participated in the Society for Immunotherapy of Cancer (SITC) 2023 conference. Her research includes the development of T-cell differentiation from iPSCs and the generation of functional CD8ab T-cells.